See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Zimmer to phase out CPT device, but FDA wary of existing inventory

Sep. 17, 2024
By Mark McCarty
The U.S. FDA reported Sept. 17 that the Zimmer Biomet Holdings Inc. CPT hip system is associated with an increased risk of thighbone fracture, a problem Zimmer acknowledged with a July 2, 2024, class II recall.
BioWorld MedTech Regulatory U.S. FDA